Clinical Trials Directory

Trials / Conditions / Recurrent Transformed B-Cell Non-Hodgkin Lymphoma

Recurrent Transformed B-Cell Non-Hodgkin Lymphoma

8 registered clinical trials studyying Recurrent Transformed B-Cell Non-Hodgkin Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingImmune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
NCT05077527
AIDS Malignancy ConsortiumPhase 1
RecruitingZanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
NCT05873712
Aseel AlsouqiPhase 2
Active Not RecruitingZanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin
NCT05202782
Northwestern UniversityPhase 2
WithdrawnVorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed A
NCT04220008
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingPolatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy
NCT04665765
City of Hope Medical CenterPhase 2
CompletedMogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
NCT03309878
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingA Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Exp
NCT03277729
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
CompletedIbrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
NCT02207062
University of WashingtonPhase 2